Genetically altered T-cells subdue leukemia

12/13/2012 | New Scientist

Genetically engineered T-cells injected into 13 people with leukemia improved each person's condition, so much so that all improved to some degree, with 10 nearing or reaching remission just three months after the injection. "The fact we got a response in all 13, you can't get better than that," said Adaptimmune CEO James Noble in Abingdon, England. His company developed the treatment. A team of University of Maryland researchers took T-cells -- which fight tumor cells -- from each patient, inserted engineered genes into the cells and re-injected them in the patients.

View Full Article in:

New Scientist

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Program Officer, Teacher Development
Knowles Science Teaching Foundation
Moorestown, NJ
Executive Director
Capitol Region Education Council (CREC)
Hartford, CT
Senior ELL Technical Assistance and Curriculum Specialist (8270)
American Institute for Researcher
Chicago, IL
Senior Researcher (8194)
American Institute for Researcher
Washington, DC
Technical Assistance Associate (8330)
American Institute for Researcher
Chicago, IL